"Aquaporin 4" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Aquaporin 4 is the major water-selective channel in the CENTRAL NERVOUS SYSTEM of mammals.
Descriptor ID |
D051401
|
MeSH Number(s) |
D12.776.157.530.400.500.040.468 D12.776.543.550.450.730.040.468 D12.776.543.585.400.730.040.577
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aquaporin 4".
Below are MeSH descriptors whose meaning is more specific than "Aquaporin 4".
This graph shows the total number of publications written about "Aquaporin 4" by people in this website by year, and whether "Aquaporin 4" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aquaporin 4" by people in Profiles.
-
Utilization of FDA approved treatments for neuromyelitis optica spectrum disorder in clinical practice: A survey study of academic neuroimmunologists. Mult Scler Relat Disord. 2023 Dec; 80:105076.
-
Effectiveness of rituximab versus oral immunosuppressive therapies in neuromyelitis optica spectrum disorder in a racially diverse cohort of subjects: A single-center retrospective study. Mult Scler Relat Disord. 2023 Jun; 74:104718.
-
Cross-immunoreactivity between bacterial aquaporin-Z and human aquaporin-4: potential relevance to neuromyelitis optica. J Immunol. 2012 Nov 01; 189(9):4602-11.
-
Crystal structure of human aquaporin 4 at 1.8 A and its mechanism of conductance. Proc Natl Acad Sci U S A. 2009 May 05; 106(18):7437-42.
-
TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int. 2008 Feb; 52(3):447-56.
-
Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochim Biophys Acta. 2003 Nov 20; 1639(3):169-76.